Quercetin: Benefits, Dosage & What the Science Says
Quercetin is one of the most abundant dietary flavonoids — found in onions, apples, berries, capers, and many vegetables — and one of the most studied polyphenols for anti-inflammatory, antioxidant, and immune-modulating applications. Its mechanisms include inhibition of NF-κB and mast cell degranulation, making it relevant for allergy support and inflammatory conditions. More recently, quercetin has gained attention as a senolytic agent — capable of selectively inducing apoptosis in senescent cells at higher doses — and as a bioavailability enhancer for resveratrol and other polyphenols via CYP enzyme inhibition.
What Is Quercetin?
Quercetin (3,3',4',5,7-pentahydroxyflavone) is a plant flavonoid found across the diet — particularly concentrated in capers (~180 mg/100g), red onions (~35–50 mg/100g), apples (~4 mg/100g), and berries. Despite its dietary ubiquity, typical daily intake from food is only 10–100 mg — far below the 500–1,000 mg/day used in most clinical trials. Supplemental quercetin is derived primarily from Japanese pagoda tree flowers (Sophora japonica / Styphnolobium japonicum), known in TCM as Huái Huā (槐花), which are among the most concentrated botanical sources.
Quercetin has a remarkably broad mechanism profile — a characteristic of many dietary polyphenols that creates both therapeutic opportunity and mechanistic complexity. Primary mechanisms include: inhibition of NF-κB transcription factor activation (reducing production of pro-inflammatory cytokines IL-1β, IL-6, TNF-α); stabilization of mast cell membranes (preventing degranulation and histamine release — the basis for its anti-allergy application); direct antioxidant activity through free radical scavenging and upregulation of Nrf2-mediated antioxidant enzymes; inhibition of 5-LOX and COX enzymes at higher concentrations; inhibition of phosphoinositide 3-kinase (PI3K) signaling relevant to inflammatory and cancer cell biology; and at the doses used in senolytic research (1,000–1,250 mg), induction of apoptosis in senescent cells via BCL-2/BCL-XL inhibition.
Bioavailability is a significant challenge with quercetin — it shares this characteristic with curcumin and resveratrol. Standard quercetin aglycone is poorly water-soluble and variably absorbed (estimated bioavailability 2–17% depending on food matrix). Quercetin glycosides (particularly quercetin-3-glucoside / isoquercetin) are more bioavailable due to active SGLT1 transport in the small intestine. Phytosome-complexed quercetin (Quercefit / Sophora japonica phytosome) achieves substantially higher bioavailability. Co-administration with bromelain (a protease from pineapple) historically used to improve quercetin absorption has limited direct pharmacokinetic evidence but is commonly seen in combination products. Quercetin inhibits UDP-glucuronosyltransferases that metabolize resveratrol, which is the basis for the quercetin + resveratrol bioavailability-enhancing combination.
Evidence-Based Benefits
Mast Cell Stabilization and Immune/Allergy Modulation
Quercetin's most clinically consistent effect in human trials is mast cell stabilization — inhibiting IgE-mediated mast cell degranulation and thereby reducing histamine, prostaglandin D2, and leukotriene release. This mechanism underpins its use for allergic rhinitis, food sensitivities, and exercise-induced bronchoconstriction. A double-blind, placebo-controlled trial found that quercetin supplementation significantly reduced seasonal allergy symptoms compared to placebo, with effects comparable to the antihistamine cromolyn sodium in mast cell inhibition studies. For individuals with histamine intolerance or chronic allergic conditions, quercetin at 500–1,000 mg/day is among the most mechanistically logical botanical interventions — its inhibition of mast cell activation is more targeted than broad anti-histamine drugs and addresses the upstream release rather than downstream receptor activity.
Anti-Inflammatory NF-κB Inhibition and Antioxidant Activity
Quercetin inhibits NF-κB activation at multiple upstream steps, reducing transcription of pro-inflammatory genes including TNF-α, IL-1β, IL-6, and COX-2. It also inhibits 5-LOX at higher concentrations — overlapping with boswellia's mechanism and making quercetin + boswellia combinations rationally anti-inflammatory through two distinct leukotriene pathways. As an antioxidant, quercetin's three-ring flavone structure enables potent free radical scavenging; it also upregulates Nrf2, inducing expression of antioxidant and detoxification enzymes (HO-1, NQO1, GPx). Multiple randomized trials have found reductions in CRP, IL-6, and oxidative stress markers with quercetin supplementation at 500–1,000 mg/day. A 2017 meta-analysis of 17 RCTs confirmed significant reductions in CRP and TNF-α with quercetin supplementation across diverse populations, with consistent effects regardless of baseline inflammatory status.
Emerging Senolytic and Cellular Aging Applications
The most compelling new application for quercetin is as a senolytic agent — a compound that selectively induces apoptosis in senescent cells (cells that have permanently exited the cell cycle but resist programmed death) while leaving healthy cells intact. Cellular senescence is a hallmark of aging, with senescent cells accumulating in tissues and secreting a pro-inflammatory cocktail (the SASP — senescence-associated secretory phenotype) that drives tissue dysfunction. The Mayo Clinic senolytic combination of quercetin (1,000 mg) + dasatinib (a cancer drug) cleared senescent cells in animal studies and has now been tested in human pilot trials in idiopathic pulmonary fibrosis and diabetic kidney disease, showing measurable reductions in senescent cell burden in tissues. Quercetin alone (without dasatinib) is being studied as a dietary senolytic at doses of 500–1,250 mg in intermittent protocols. This application is genuinely exciting but remains in early-phase human investigation — it warrants monitoring rather than definitive clinical claims.
Recommended Dosage
| Form | Typical Dose | Timing | Notes |
|---|---|---|---|
| Quercetin phytosome (Quercefit® / Sophora japonica phytosome) | 250–500 mg daily (providing quercetin equivalent) | With meals | 20× greater bioavailability than standard quercetin aglycone; phospholipid-complexed; preferred form for consistent clinical results; used in most modern clinical trials |
| Isoquercetin (quercetin-3-glucoside) | 500–1,000 mg daily | With meals | Glycoside form absorbed via SGLT1 transporter; 3–5× better bioavailability than standard quercetin aglycone; more expensive than standard quercetin but worth it for consistent results |
| Standard quercetin aglycone + bromelain | 500–1,000 mg quercetin + 100–200 mg bromelain | Between meals for anti-inflammatory effect; with meals for tolerance | Classic combination; bromelain improves mucosal absorption; most affordable option; variable bioavailability — take with fat-containing food to improve absorption |
| Quercetin senolytic protocol (intermittent) | 1,000–1,250 mg quercetin for 2 consecutive days, then 5+ days off | With meals on dosing days | Replicates Mayo Clinic senolytic research protocol; intermittent dosing is proposed to allow senescent cell clearance between cycles; long-term human safety at this dose level under study; discuss with physician |
500–1,000 mg/day for anti-inflammatory and allergy applications. For senolytic protocols: 1,000–1,250 mg intermittently (2 days on, 5 days off or weekly dosing). Use bioavailable forms — phytosome or isoquercetin preferred.
Safety, Side Effects & Interactions
How to Choose a Quality Quercetin
Form selection is the most important quality decision with quercetin, given the wide bioavailability range between forms. Standard quercetin aglycone powder has documented absorption variability and should be taken with fat-containing food. Isoquercetin (quercetin-3-glucoside) is reliably 3–5× more bioavailable. Quercetin phytosome (Quercefit, marketed by Indena) achieves the highest bioavailability in comparative studies and is used in the most recent clinical trials.
For allergy and anti-inflammatory applications, 500 mg/day of a bioavailable form (phytosome or isoquercetin) is a rational starting point. For senolytic applications, doses used in clinical investigation are 1,000–1,250 mg on intermittent protocols — if this application interests you, monitor the emerging trial literature (trials at Mayo Clinic, University of Minnesota) and discuss with your physician, as this is not yet routine clinical practice.
Source quality matters — quercetin is typically derived from Sophora japonica flowers (a clean, concentrated botanical source) or from tobacco plant (Nicotiana tabacum, used in industrial extraction). The label should specify the botanical source; Sophora japonica is preferred. Third-party testing for heavy metals and verification of quercetin content by HPLC (not just label claim) ensures you are getting what you pay for.
Looking for a quality source? We recommend products that meet third-party testing standards.
Affiliate disclosure: We may earn a commission on qualifying purchases at no extra cost to you.
Works Well With
Research suggests Quercetin may complement:
Traditional Use
Frequently Asked Questions
What is quercetin best used for?
Quercetin has several distinct evidence-supported applications: allergy and histamine support (mast cell stabilization — one of the strongest mechanistic cases), anti-inflammatory maintenance (NF-κB inhibition, CRP and IL-6 reduction confirmed in meta-analyses), respiratory health during allergy season, and as an adjunct to resveratrol (quercetin inhibits the glucuronidation enzymes that rapidly metabolize resveratrol, potentially raising plasma resveratrol levels). The emerging senolytic application at higher intermittent doses is scientifically intriguing but more experimental. Most adults aged 45–65 with chronic low-grade inflammation or seasonal allergies will find the anti-inflammatory and mast cell applications most immediately relevant.
Does quercetin help with allergies?
Yes — this is one of quercetin's best-supported clinical applications. Quercetin stabilizes mast cell membranes and inhibits IgE-mediated degranulation, reducing release of histamine and other allergy mediators. This mechanism is distinct from antihistamine drugs (which block histamine receptors after release) — quercetin prevents the release upstream. Comparative studies in mast cell models have found quercetin comparable to cromolyn sodium (a pharmaceutical mast cell stabilizer) at sufficient concentrations. For seasonal allergies, consistent daily use starting 4–6 weeks before allergy season — rather than reactive use during peak symptoms — appears to produce better outcomes, consistent with the mechanism of membrane stabilization over time rather than acute histamine blockade.
What is a senolytic and how does quercetin work as one?
Senescent cells are cells that have permanently stopped dividing but resist dying — they accumulate in tissues with age and secrete a pro-inflammatory mix of cytokines (the SASP) that damages surrounding tissue. Senolytics are compounds that selectively trigger apoptosis in senescent cells while leaving healthy cells intact. Quercetin's senolytic mechanism involves inhibition of BCL-2 and BCL-XL — anti-apoptotic proteins that senescent cells upregulate to survive. At doses of 1,000–1,250 mg (in combination with the cancer drug dasatinib in some protocols), quercetin has been shown in animal models and early human trials to reduce the burden of senescent cells in tissues including fat, lung, and kidney. The Mayo Clinic is the primary research center driving this work. Quercetin alone (without dasatinib) is being explored as a dietary senolytic with potentially gentler but real effects — this is frontier science, not established clinical practice.
Why should quercetin be separated from iron supplements?
Quercetin chelates iron — it binds iron ions to form stable quercetin-iron complexes, reducing the free iron available for intestinal absorption. This is actually part of quercetin's antioxidant mechanism (chelating free iron prevents it from participating in Fenton reactions that generate hydroxyl radicals) but is a practical concern if you are supplementing iron for deficiency. Taking quercetin simultaneously with iron supplements or immediately after an iron-rich meal (red meat, fortified cereals) can significantly reduce iron absorption. Separate quercetin from iron-containing supplements or iron-rich meals by at least 2 hours. For individuals who are iron-replete or even borderline high-iron (common in postmenopausal women and older men), the iron-chelating property may actually be a secondary benefit.
Is quercetin better absorbed with bromelain?
The quercetin + bromelain combination is widely sold based on claims that bromelain (a pineapple-derived protease) enhances quercetin absorption. The evidence is mixed — bromelain does appear to improve mucosal permeability and may assist in quercetin transport, but pharmacokinetic studies comparing quercetin with and without bromelain are limited and inconsistent. The more important bioavailability difference is between quercetin forms: phytosome quercetin and isoquercetin provide dramatically better and more reproducible absorption than standard quercetin aglycone with or without bromelain. If you're choosing between a standard quercetin + bromelain product and a quercetin phytosome product, the phytosome will likely deliver more quercetin to circulation. Both bromelain and quercetin independently have anti-inflammatory activity, so combination products offer complementary benefits regardless of the absorption question.
Can quercetin be combined with resveratrol?
Yes — and this combination is mechanistically interesting for two reasons. First, quercetin inhibits UDP-glucuronosyltransferases and sulfotransferases — the phase II enzymes that rapidly metabolize resveratrol in the gut wall and liver, sharply limiting bioavailability. By inhibiting these enzymes, quercetin may raise plasma resveratrol levels when taken simultaneously. Second, their mechanisms are complementary: quercetin primarily inhibits NF-κB and mast cell activation; resveratrol primarily activates SIRT1 and AMPK. These are additive rather than redundant anti-inflammatory and longevity pathways. Take both with a fat-containing meal for optimal absorption. The combination is well-tolerated based on individual safety profiles of both compounds.
References
- Mlcek J et al. Quercetin and its anti-allergic immune response. Molecules. 2016;21(5):623. — PMID:26787855
- Mohammadi-Sartang M et al. The effect of quercetin supplementation on lipid profiles and inflammatory biomarkers. Crit Rev Food Sci Nutr. 2017;57(16):3347–3358. — PMID:28621243
- Zhu Y et al. New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, navitoclax and A1331852. Aging (Albany NY). 2017;9(3):955–963. — PMID:30654737
- Russo M et al. The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem Pharmacol. 2012;83(1):6–15. — PMID:21856292
Last reviewed: April 21, 2026. For informational purposes only. See full disclaimer. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
AI & Developer Endpoint
/data/supplements/quercetin.json
This supplement profile ships machine-readable JSON-LD and a structured data endpoint for AI systems and developers.